News from the healthcare data industry
December 16, 2021 COTA Team Majority of providers also believe all cancer clinical trials should include real-world data to ensure diverse representation in treatments. COTA announced insights from a study...
Posted on December 17, 2021 Company poised to transform personalized drug development and clinical healthcare in 2022, following series of key pharma partnerships leveraging its leading genomics platform and global...
CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) Software-as-a-Service (SaaS) and Real-world Evidence (RWE) solutions for life science companies and healthcare providers, announced today...
CHICAGO, Dec. 16, 2021 /PRNewswire/ — EVERSANA, the pioneer of next generation services to the global life sciences industry, today announced an agreement with Janssen Research & Development, LLC (Janssen) to transform clinical...
NEW YORK and SALT LAKE CITY, Dec. 16, 2021 /PRNewswire/ — Protocol First, a software solutions provider focused on accelerating clinical research, will become a wholly owned subsidiary of Flatiron HealthⓇ, the two companies...
ALPHARETTA, Ga., Dec. 15, 2021 /PRNewswire/ — Ciox Health™, a leading health technology company, today announced the release of Ciox Data Utilities™. Ciox Data Utilities is a suite of solutions designed to add value...
Palo Alto, California, Dec. 15, 2021 (GLOBE NEWSWIRE) — Health Gorilla, the leading provider of interoperability solutions in Latin America, and Snabb, Chile’s most prominent healthcare scheduling platform, have partnered...
CAMBRIDGE, Mass., Dec. 15, 2021 /PRNewswire/ — nference, the AI-driven health technology company, announced today publication of a peer-reviewed study in Med that analyzed Mayo Clinic based data with nference artificial intelligence (AI) software to...
SAN FRANCISCO and DOVER, Del., Dec. 15, 2021 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
December 11, 2021 09:35 AM Eastern Standard Time BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX®▼ (daratumumab)-based...